Post-July 1, 2022 Filing Requirements and Deadlines

Patentee and Medicine Information
Information Timing Patent Act Regulations Form
Identity of medicine, patentee and patent(s)

Earliest of:

Seven (7) days after the date the first Notice of Compliance issued

Seven (7) days after the date the medicine is first offered for sale in Canada

80(1)(a)
80(2)(a)
3(1) 3(2)
3(3)
1
Updating information on identity of medicine/patentee Within thirty (30) days after any modification of information 3(4) 1
Price and Sales Data
Information Timing Patent Act Regulations Form

Price and sales data for the medicine sold to province/territory in Canada

Publicly available ex-factory price sold in Australia, Belgium, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden and United Kingdom

When a drug is first offered for sale in Canada, no later than thirty (30) days after the first day of sales

On or before July 30 (January 1 to June 30 reporting period)

On or before January 30 (July 1 to December 31 reporting period)

80(1)(b) 80(2)(b)

4(1)

4(2)

2
Revenue and R&D Expenditures
Information Timing Patent Act Regulations Form
Revenues from sales and expenditures on R&D On or before March 1 of each year 88(1) 88(2) 5, 6 3
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: